Philips Begins Pivotal THOR Trial of Combined Device to Treat PAD
November 4, 2024—Royal Philips announced enrollment of the first patient in THOR, a United States investigational device exemption (IDE) clinical trial of the company’s combined laser atherectomy and intravascular lithotripsy catheter for the treatment of peripheral artery disease (PAD).
